≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Neuroendocrine tumor and carcinoma of pancreas

PheWeb

C3_PANCREAS_NEUROENDOCRINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Cancer registry: Topography ICD-O-3 C25
Cancer registry: Morphology ICD-O-3 8240|8246|8249
Cancer registry: Behaviour codes 3

1170

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

109

diagram downward connector

Check minimum number of events None

109

diagram downward connector

Include endpoints None

109

diagram downward connector
C3_PANCREAS_NEUROENDOCRINE

Extra metadata

First used in FinnGen datafreeze DF8

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 109 46 63
Unadjusted prevalence (%) 0.03 0.02 0.04
Mean age at first event (years) 59.58 56.64 61.73

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_PANCREAS_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of pancreas
GWS hits:

Survival analyses between endpoints

↥

Plot

before Neuroendocrine tumor and carcinoma of pancreas
after Neuroendocrine tumor and carcinoma of pancreas

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Neuroendocrine tumor and carcinoma of pancreas

↥